logo
  

Des Naughton, MD Of Nicoventures, To Leave The BAT Group

British American Tobacco Plc. (BATS.L,BTI) on Thursday announced certain management changes, under which the company said Des Naughton, Managing Director of Nicoventures would leave the BAT Group on February 28, 2015, for focusing on new business opportunities.

The company named Kingsley Wheaton, as Managing Director - Next Generation Products with effect from January 1, 2015. This new role will include leadership of 'tobacco heating products' which will be managed alongside the firm's emerging nicotine businesses. Kingsley has been with the company for 18 years and a member of the board since 2012. He will be succeeded as Group Corporate & Regulatory Affairs Director by Jerome Abelman, currently Assistant General Counsel - Corporate & Commercial, also with effect from January 1.

In addition, the firm said Neil Withington, Group Legal Director & General Counsel, has plans to retire as of April 30, 2015. Following his departure, the group functions will be integrated under Jerry Abelman's leadership.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
AbbVie (ABBV) Monday announced a collaboration and option-to-license agreement with Gilgamesh Pharmaceuticals, a clinical stage neuroscience biotech firm, to develop next-generation treatment approaches and unmet needs in psychiatric disorders. AbbVie noted that the first-generation compounds may... Healthwest Minerals, Inc. d/b/a Mt. Capra Products has recalled 1,506 boxes of Goat Milk Formula Recipe Kit, also urging consumers to immediately discontinue use of the product as infant formula. The firm does not recommend using this product for infants from 0-12 months of age. Major companies, including Amazon.com Inc., Microsoft Corp., Morgan Stanley, Pfizer and others, have announced around 15 billion euros or $16.2 billion worth foreign investments in France as part of the country's annual 'Choose France' business summit, reports said. French President Emmanuel Macron kicks off the summit of 180 CEOs and executives on Monday, aiming to showcase foreign investment.

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT